ReviewPharmaceutics2022
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems.
Lisha Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewPharmaceutics2022
Lisha Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.